chr20-1478599-C-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001122962.2(SIRPB2):c.460G>T(p.Asp154Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000477 in 1,565,442 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D154N) has been classified as Uncertain significance.
Frequency
Consequence
NM_001122962.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SIRPB2 | NM_001122962.2 | c.460G>T | p.Asp154Tyr | missense_variant | 3/5 | ENST00000359801.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SIRPB2 | ENST00000359801.8 | c.460G>T | p.Asp154Tyr | missense_variant | 3/5 | 2 | NM_001122962.2 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000453 AC: 69AN: 152194Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000479 AC: 103AN: 214944Hom.: 0 AF XY: 0.000416 AC XY: 49AN XY: 117866
GnomAD4 exome AF: 0.000480 AC: 678AN: 1413130Hom.: 2 Cov.: 34 AF XY: 0.000453 AC XY: 316AN XY: 697000
GnomAD4 genome AF: 0.000453 AC: 69AN: 152312Hom.: 0 Cov.: 32 AF XY: 0.000497 AC XY: 37AN XY: 74480
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 15, 2021 | The c.460G>T (p.D154Y) alteration is located in exon 3 (coding exon 3) of the SIRPB2 gene. This alteration results from a G to T substitution at nucleotide position 460, causing the aspartic acid (D) at amino acid position 154 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at